Alkermes (ALKS) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026)
Alkermes (ALKS) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 5.84% |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -11.73% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 7.65% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 0.86% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 27.15% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -6.48% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 11.32% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 11.90% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | 28.35% |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn | -12.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.32% |
| Mar 31, 2026 | -11.76% |
| Dec 31, 2025 | -0.18% |
| Sep 30, 2025 | -8.87% |
| Jun 30, 2025 | -10.79% |
| Mar 31, 2025 | -11.44% |
| Dec 31, 2024 | -12.62% |
| Sep 30, 2024 | -12.85% |
| Jun 30, 2024 | -13.48% |
| Mar 31, 2024 | -13.44% |
| Dec 31, 2023 | -13.45% |
| Sep 30, 2023 | -2.67% |
| Jun 30, 2023 | -3.63% |
| Mar 31, 2023 | -3.96% |
| Dec 31, 2022 | -14.94% |
| Sep 30, 2022 | -1.49% |
| Jun 30, 2022 | 1.10% |
| Mar 31, 2022 | 1.71% |
| Dec 31, 2021 | 3.23% |
| Sep 30, 2021 | 3.97% |